The $44.55 Billion Opportunity: Autologous Cell Therapy’s Next Healthcare Mega-Trend

March 5, 2026
The $44.55 Billion Opportunity: Why Autologous Cell Therapy Represents Healthcare's Next Mega-Trend The Market Size Debate and Why Methodology Matters Financial journalists frequently cite a single market projection as definitive: autologous cell therapy will reach $44.55 billion by 2033. This figure originates from Astute Analytica's research, which projects growth from $10.12 billion in 2024 at […]
Read the full article

Stem Cell Therapy Success Rates and Investor Risk in 2026

January 6, 2026
Stem Cell Therapy Success Rates and the Investor Risk Equation Capital Markets Have Repriced Regenerative Medicine Stem cell therapy entered 2026 with investor sentiment fundamentally reset. Risk now anchors capital allocation decisions across regenerative medicine, shaped in part by high-profile research programs that repeatedly failed to translate promise into durable clinical outcomes. What once looked […]
Read the full article

Mike Doustdar: Inside Novo Nordisk’s Bold New Era of Leadership

November 20, 2025
From Photocopy Clerk to CEO Maziar “Mike” Doustdar has one of the most impressive long-term rise stories in global pharmaceuticals. When he joined Novo Nordisk in 1992, he started in a junior administrative position. Over the years, he worked across multiple international markets, taking on roles in Asia, Europe, and the Middle East. His on-the-ground […]
Read the full article

Why Should You Invest In Healthcare Innovation?

August 24, 2021
Healthcare is not just about diseases and treatments. Pharmaceuticals, medical gadgets, health insurance, and multi-speciality hospitals are just a few of the many types of healthcare available today. There is a lot of money to be made in each of these fields. Investments in this industry have good and negative tendencies, just as in other […]
Read the full article

About CEO Today

CEO Today Online and CEO Today magazine are dedicated to providing CEOs and C-level executives with the latest corporate developments, business news and technological innovations.

Follow CEO Today

chevron-right-circle